436 related articles for article (PubMed ID: 29398194)
1. Vestibular symptoms as the presenting feature of progressive supranuclear palsy.
Haggstrom L; Brew B; Sutton I; Tisch S
J Clin Neurosci; 2018 Apr; 50():74-76. PubMed ID: 29398194
[TBL] [Abstract][Full Text] [Related]
2. Progressive supranuclear palsy.
Giagkou N; Höglinger GU; Stamelou M
Int Rev Neurobiol; 2019; 149():49-86. PubMed ID: 31779824
[TBL] [Abstract][Full Text] [Related]
3. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
[TBL] [Abstract][Full Text] [Related]
4. Motor, cognitive and behavioral differences in MDS PSP phenotypes.
Picillo M; Cuoco S; Tepedino MF; Cappiello A; Volpe G; Erro R; Santangelo G; Pellecchia MT; Barone P;
J Neurol; 2019 Jul; 266(7):1727-1735. PubMed ID: 30989369
[TBL] [Abstract][Full Text] [Related]
5. Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy.
Williams DR; Holton JL; Strand K; Revesz T; Lees AJ
Mov Disord; 2007 Nov; 22(15):2235-41. PubMed ID: 17712855
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
Williams DR; de Silva R; Paviour DC; Pittman A; Watt HC; Kilford L; Holton JL; Revesz T; Lees AJ
Brain; 2005 Jun; 128(Pt 6):1247-58. PubMed ID: 15788542
[TBL] [Abstract][Full Text] [Related]
7. The phenotypic spectrum of progressive supranuclear palsy.
Respondek G; Höglinger GU
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S34-6. PubMed ID: 26421392
[TBL] [Abstract][Full Text] [Related]
8. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
Litvan I; Mangone CA; McKee A; Verny M; Parsa A; Jellinger K; D'Olhaberriague L; Chaudhuri KR; Pearce RK
J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):615-20. PubMed ID: 8648326
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of progressive supranuclear palsy in Yonago: change throughout a decade.
Takigawa H; Kitayama M; Wada-Isoe K; Kowa H; Nakashima K
Brain Behav; 2016 Dec; 6(12):e00557. PubMed ID: 28031995
[TBL] [Abstract][Full Text] [Related]
10. Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism.
Assogna F; Pellicano C; Cravello L; Savini C; Macchiusi L; Pierantozzi M; Stefani A; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
Brain Behav; 2019 Dec; 9(12):e01448. PubMed ID: 31743601
[TBL] [Abstract][Full Text] [Related]
11. Which ante mortem clinical features predict progressive supranuclear palsy pathology?
Respondek G; Kurz C; Arzberger T; Compta Y; Englund E; Ferguson LW; Gelpi E; Giese A; Irwin DJ; Meissner WG; Nilsson C; Pantelyat A; Rajput A; van Swieten JC; Troakes C; Josephs KA; Lang AE; Mollenhauer B; Müller U; Whitwell JL; Antonini A; Bhatia KP; Bordelon Y; Corvol JC; Colosimo C; Dodel R; Grossman M; Kassubek J; Krismer F; Levin J; Lorenzl S; Morris H; Nestor P; Oertel WH; Rabinovici GD; Rowe JB; van Eimeren T; Wenning GK; Boxer A; Golbe LI; Litvan I; Stamelou M; Höglinger GU;
Mov Disord; 2017 Jul; 32(7):995-1005. PubMed ID: 28500752
[TBL] [Abstract][Full Text] [Related]
12. The language profile of progressive supranuclear palsy.
Catricalà E; Boschi V; Cuoco S; Galiano F; Picillo M; Gobbi E; Miozzo A; Chesi C; Esposito V; Santangelo G; Pellecchia MT; Borsa VM; Barone P; Garrard P; Iannaccone S; Cappa SF
Cortex; 2019 Jun; 115():294-308. PubMed ID: 30884283
[TBL] [Abstract][Full Text] [Related]
13. J. Clifford Richardson and 50 years of progressive supranuclear palsy.
Williams DR; Lees AJ; Wherrett JR; Steele JC
Neurology; 2008 Feb; 70(7):566-73. PubMed ID: 18268249
[TBL] [Abstract][Full Text] [Related]
14. [Progressive supranuclear palsy-Richardson syndrome with visual attention disturbance (Holmes and Horrax) and ataxie optique (Garcin): a case report].
Morishima R; Bandoh M; Sunami Y; Isozaki E
Rinsho Shinkeigaku; 2019 Nov; 59(11):730-735. PubMed ID: 31656263
[TBL] [Abstract][Full Text] [Related]
15. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
Litvan I; Campbell G; Mangone CA; Verny M; McKee A; Chaudhuri KR; Jellinger K; Pearce RK; D'Olhaberriague L
Brain; 1997 Jan; 120 ( Pt 1)():65-74. PubMed ID: 9055798
[TBL] [Abstract][Full Text] [Related]
16. [Progressive supranuclear palsy: what's new?].
Levy R
Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):191-201. PubMed ID: 21690028
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.
Pellicano C; Assogna F; Cellupica N; Piras F; Pierantozzi M; Stefani A; Cerroni R; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
Parkinsonism Relat Disord; 2017 Dec; 45():50-56. PubMed ID: 29037499
[TBL] [Abstract][Full Text] [Related]
18. Gait Analysis in Progressive Supranuclear Palsy Phenotypes.
Picillo M; Ricciardi C; Tepedino MF; Abate F; Cuoco S; Carotenuto I; Erro R; Ricciardelli G; Russo M; Cesarelli M; Barone P; Amboni M
Front Neurol; 2021; 12():674495. PubMed ID: 34177779
[TBL] [Abstract][Full Text] [Related]
19. Differences in aphasia syndromes between progressive supranuclear palsy-Richardson's syndrome, behavioral variant frontotemporal dementia and Alzheimer's dementia.
Ransmayr L; Fuchs A; Ransmayr-Tepser S; Kommenda R; Kögl M; Schwingenschuh P; Fellner F; Guger M; Eggers C; Darkow R; Mangesius S; Ransmayr G
J Neural Transm (Vienna); 2022 Aug; 129(8):1039-1048. PubMed ID: 35821453
[TBL] [Abstract][Full Text] [Related]
20. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia.
Kanazawa M; Tada M; Onodera O; Takahashi H; Nishizawa M; Shimohata T
Parkinsonism Relat Disord; 2013 Dec; 19(12):1149-51. PubMed ID: 23916652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
